home / stock / bcab / bcab quote
Last: | $2.54 |
---|---|
Change Percent: | -0.44% |
Open: | $2.26 |
Close: | $2.54 |
High: | $2.55 |
Low: | $2.23 |
Volume: | 295,211 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.54 | $2.26 | $2.54 | $2.55 | $2.23 | 295,211 | 04-26-2024 |
$2.25 | $2.32 | $2.25 | $2.34 | $2.2075 | 398,980 | 04-25-2024 |
$2.35 | $2.24 | $2.35 | $2.38 | $2.24 | 393,327 | 04-24-2024 |
$2.24 | $2.18 | $2.24 | $2.32 | $2.18 | 672,714 | 04-23-2024 |
$2.18 | $2.11 | $2.18 | $2.18 | $2.005 | 872,008 | 04-22-2024 |
$2.105 | $2.42 | $2.105 | $2.505 | $2.1 | 796,590 | 04-19-2024 |
$2.43 | $2.54 | $2.43 | $2.55 | $2.39 | 362,131 | 04-18-2024 |
$2.53 | $2.69 | $2.53 | $2.75 | $2.515 | 564,399 | 04-17-2024 |
$2.625 | $2.85 | $2.625 | $2.85 | $2.6101 | 484,092 | 04-16-2024 |
$2.86 | $3.13 | $2.86 | $3.14 | $2.81 | 599,471 | 04-15-2024 |
$3.13 | $3.28 | $3.13 | $3.32 | $3.11 | 485,677 | 04-12-2024 |
$3.35 | $3.25 | $3.35 | $3.43 | $3.215 | 276,128 | 04-11-2024 |
$3.25 | $3.62 | $3.25 | $3.62 | $3.21 | 477,460 | 04-10-2024 |
$3.57 | $3.79 | $3.57 | $3.87 | $3.515 | 506,651 | 04-09-2024 |
$3.83 | $3.97 | $3.83 | $3.97 | $3.68 | 327,428 | 04-08-2024 |
$3.8 | $3.94 | $3.8 | $3.99 | $3.7311 | 1,020,589 | 04-05-2024 |
$3.92 | $3.78 | $3.92 | $4.02 | $3.685 | 1,507,091 | 04-04-2024 |
$3.7 | $3.55 | $3.7 | $3.9676 | $3.55 | 1,279,467 | 04-03-2024 |
$3.52 | $3.39 | $3.52 | $3.67 | $3.17 | 928,645 | 04-02-2024 |
$3.39 | $3.5 | $3.39 | $3.85 | $3.26 | 1,201,504 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
BioAtla Inc. Company Name:
BCAB Stock Symbol:
NASDAQ Market:
SAN DIEGO, April 24, 2024 (GLOBE NEWSWIRE) -- BioAtla, Inc. (NASDAQ:BCAB), a global clinical-stage biotechnology company focused on the developm...
SAN DIEGO, April 24, 2024 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced a poster presentation at the upcomin...
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...